News

Donanemab receives positive opinion from the Committee for Medicinal Products for Human Use (CHMP) in early symptomatic Alzheimer's disease
The opinion will now be referred to the European Commission for final regulatory decision on donanemab  INDIANAPOLIS, July 25 ...
ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression
Biogen Inc. (Nasdaq: BIIB) announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines ...
Pharmaceutical Technology on MSN22h
CHMP rejects Elevidys in latest setback for Sarepta
In the latest of a string of issues Sarepta has faced, the CHMP said it was recommending against approval as the pivotal ...
InvestorsHub on MSN1d
Positive CHMP Opinion for Gilead’s Lenacapavir in HIV Prevention
Gilead Sciences (NASDAQ:GILD) announced on Friday that the European Medicines Agency’s Committee for Medicinal Products for ...
FiercePharma11y
Meeting highlights from the Committee for Medicinal Products for Human ...
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20-23 January 2014 By Emily Wasserman Jan 24, 2014 7:35am Pharma ...
TRYNGOLZA® (olezarsen) recommended for EU approval by CHMP for familial chylomicronemia syndrome (FCS)
Sobi® (STO: SOBI) and Ionis Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion of ...
KalVista Gets CHMP Backing for Ekterly in Hereditary Angioedema
KalVista on Friday said the recommendation by the European Medicines Agency's Committee for Medicinal Products for Human Use covers Ekterly in people ages 12 and older for the symptomatic treatment of ...
Morningstar4mon
The Committee for Medicinal Products for Human Use (CHMP) reaffirms ...
STOCKHOLM, Feb. 28, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced today that the Committee for Medicinal Products for Human Use (CHMP) of the ...
FierceBiotech16y
Committee For Medicinal Products For Human Use Post-Authorisation ...
LONDON, Oct. 23, 2008-On 23 October 2008 the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion** to recommend the variation to the terms of the marketing ...
FierceBiotech18y
Press Release: Committee for Medicinal Products for Human Use Summary ...
Committee for Medicinal Products for Human Use Summary of Positive Opinion for Optaflu LONDON, April 26, 2007-On 26 April 2007 the Committee for Medicinal Products for Human Use (CHMP) adopted a ...
TRYNGOLZA® (olezarsen) recommended for approval in the EU by CHMP for familial chylomicronemia syndrome (FCS)
TRYNGOLZA was approved in the United States in December 2024 and granted orphan designation in the EU. Olezarsen is also being evaluated for sHTG, a serious condition defined by dangerously high ...
FiercePharma11y
Meeting highlights from the Committee for Medicinal Products for Human ...
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP), 16-19 September 2013 This press release provides an overview of the opinions adopted at the September 2013 ...